64 related articles for article (PubMed ID: 7891222)
21. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms.
Schuetz EG; Furuya KN; Schuetz JD
J Pharmacol Exp Ther; 1995 Nov; 275(2):1011-8. PubMed ID: 7473127
[TBL] [Abstract][Full Text] [Related]
22. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
[TBL] [Abstract][Full Text] [Related]
23. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
Beck WT; Grogan TM; Willman CL; Cordon-Cardo C; Parham DM; Kuttesch JF; Andreeff M; Bates SE; Berard CW; Boyett JM; Brophy NA; Broxterman HJ; Chan HS; Dalton WS; Dietel M; Fojo AT; Gascoyne RD; Head D; Houghton PJ; Srivastava DK; Lehnert M; Leith CP; Paietta E; Pavelic ZP; Weinstein R
Cancer Res; 1996 Jul; 56(13):3010-20. PubMed ID: 8674056
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.
Raghu G; Park SW; Roninson IB; Mechetner EB
Exp Hematol; 1996 Aug; 24(10):1258-64. PubMed ID: 8765502
[TBL] [Abstract][Full Text] [Related]
26. Multidrug resistance and malignancy in human osteosarcoma.
Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
[TBL] [Abstract][Full Text] [Related]
27. Detection of the MDR1 P-glycoprotein expression and function.
Mechetner E
Methods Mol Biol; 2007; 378():175-93. PubMed ID: 18605086
[TBL] [Abstract][Full Text] [Related]
28. Expression of MDR1/p-glycoprotein and multidrug resistance-associated protein in childhood solid tumours.
Oda Y; Röse I; Radig K; Wagemann W; Mittler U; Roessner A
Virchows Arch; 1997 Feb; 430(2):99-105. PubMed ID: 9083512
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.
Scheper RJ; Broxterman HJ; Scheffer GL; Kaaijk P; Dalton WS; van Heijningen TH; van Kalken CK; Slovak ML; de Vries EG; van der Valk P
Cancer Res; 1993 Apr; 53(7):1475-9. PubMed ID: 7680954
[TBL] [Abstract][Full Text] [Related]
30. MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.
Tóth K; Vaughan MM; Peress NS; Slocum HK; Rustum YM
Am J Pathol; 1996 Sep; 149(3):853-8. PubMed ID: 8780389
[TBL] [Abstract][Full Text] [Related]
31. Expression of the multidrug resistance, MDR1, gene in neuroblastomas.
Goldstein LJ; Fojo AT; Ueda K; Crist W; Green A; Brodeur G; Pastan I; Gottesman MM
J Clin Oncol; 1990 Jan; 8(1):128-36. PubMed ID: 2295903
[TBL] [Abstract][Full Text] [Related]
32. Expression of MDR1 (multidrug resistance) gene and its protein in normal human kidney.
Ernest S; Rajaraman S; Megyesi J; Bello-Reuss EN
Nephron; 1997; 77(3):284-9. PubMed ID: 9375821
[TBL] [Abstract][Full Text] [Related]
33. Multiple drug-resistant gene 1 in children with steroid-sensitive nephrotic syndrome.
Funaki S; Takahashi S; Wada N; Murakami H; Harada K
Pediatr Int; 2008 Apr; 50(2):159-61. PubMed ID: 18353050
[TBL] [Abstract][Full Text] [Related]
34. Expression of MDR1 mRNA and encoding P-glycoprotein in archival formalin-fixed paraffin-embedded gall bladder cancer tissues.
Cao L; Duchrow M; Windhövel U; Kujath P; Bruch HP; Broll R
Eur J Cancer; 1998 Sep; 34(10):1612-7. PubMed ID: 9893638
[TBL] [Abstract][Full Text] [Related]
35. Multidrug resistance gene (MDR 1) expression in neuro-axial tumours of children and young adults.
Billson AL; Palmer JB; Walker DA; Lowe J
Br J Neurosurg; 1994; 8(5):585-91. PubMed ID: 7857540
[TBL] [Abstract][Full Text] [Related]
36. Molecular aspects of adrenal tumours.
McNicol AM
Minerva Endocrinol; 1995 Mar; 20(1):9-13. PubMed ID: 7651288
[No Abstract] [Full Text] [Related]
37. Correlation of MDR1 gene expression with chemotherapy in neuroblastoma.
Bourhis J; Bénard J; Hartmann O; Boccon-Gibod L; Lemerle J; Riou G
J Natl Cancer Inst; 1989 Sep; 81(18):1401-5. PubMed ID: 2778826
[TBL] [Abstract][Full Text] [Related]
38. Multidrug Resistance in Acute Leukaemia: A Comparative Study of Immunocytochemical and RNA Slot Blot Detection of P-glycoprotein Expression.
Lyttelton MP; Hart S; Ganeshaguru K; Prentice HG; Hoffbrand AV; Mehta AB
Leuk Lymphoma; 1991; 5(5-6):357-64. PubMed ID: 27463346
[TBL] [Abstract][Full Text] [Related]
39. Multidrug resistance in ocular melanoma.
McNamara M; Clynes M; Dunne B; NicAmhlaoibh R; Lee WR; Barnes C; Kennedy SM
Br J Ophthalmol; 1996 Nov; 80(11):1009-12. PubMed ID: 8976731
[TBL] [Abstract][Full Text] [Related]
40. Human brain tumors: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells.
Fattori S; Becherini F; Cianfriglia M; Parenti G; Romanini A; Castagna M
Virchows Arch; 2007 Jul; 451(1):81-7. PubMed ID: 17593388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
